Greenberg Traurig

International firm Greenberg Traurig provides a full suite of IP services, including patent and trademark litigation, IP prosecution and transactions. The firm is recommended for trademark prosecution and contentious matters, copyright, and patent litigation, specifically in pharmaceutical disputes.

Key practitioners at the firm include Jonathan Ball, Ian Ballon, Scott Bornstein, David Dykeman, David Greenberg, Susan Heller, Allan Kassenoff, Richard Pettus and Joshua Raskin.

Bornstein is co-managing partner of the New York office and co-chair of the global IP and technology group. He is well-versed in patent litigation, often representing generic pharmaceutical makers. Ballon, who specializes in copyright and entertainment matters, is also co-chair of the firm’s global IP and technology group.

2022 client testimonials

"We have had a long-standing relationship with GT dating back many years. The quality of work and global reach are both key factors in choosing the firm."

"The GT team provides practical advice, with an approach similar to in-house counsel. This is a valuable attribute for our company."

"Greenberg Traurig has a deep knowledge of all aspects of our business."

"GT provides solutions and guidance targeted to our specific needs and corporate culture."

"The firm is proactive and willing to collaborate with multiple parties to achieve the best results."

"The client service is excellent," says a client who added: "They have a deep knowledge of our business and business history."

"GT provides practical advice for protecting our brand in an efficient matter," says another client who chose the firm for its "breadth of experience".

A client praised the "impressive, responsive team led by Mark Galis". The client said: "They do an excellent job of thinking through complex issues and providing suggestions on how to handle them. They were well organised in keeping track of our matters."

The firm was recently active for longstanding client Teva in a Hatch-Waxman patent dispute related to the branded drug Contrave. On appeal before the Federal Circuit, the panel issued a precedential decision that reversed a lower court decision in part and held the patents at issue were obvious as a matter of law.

In addition, the firm was hired by JP Morgan to defend against an inventor’s allegations of patent infringement and demand for over $50 million in damages.

Greenberg Traurig continues to manage, develop and assist in growing a major portion of the worldwide patent assets of Verizon  Media. Additional patent clients include Deezer and StrongArm Technologies.